Angiogenesis and lymphangiogenesis in the spectrum of leprosy and its reactional forms
- PMID: 24040306
- PMCID: PMC3765444
- DOI: 10.1371/journal.pone.0074651
Angiogenesis and lymphangiogenesis in the spectrum of leprosy and its reactional forms
Abstract
Background: Angiogenesis and lymphangiogenesis are the processes of neovascularization that evolve from preexisting blood and lymphatic vessels. There are few studies on angiogenesis and none on lymphangiogenesis in leprosy. Thus, the role of neovascularization in the pathophysiological mechanisms of the disease was studied across the spectrum of leprosy, its reactional states and its residual lesions.
Methodology/principal findings: Seventy-six biopsies of leprosy skin lesions and seven healthy controls were selected. Fifty-five serum samples were used for the detection of CD105 by ELISA. Histological sections were stained with antibodies against CD31 (blood and lymphatic vessels), D2-40/podoplanin (lymphatic vessels), and CD105/endoglin (neovessels). Microvessels were counted in 100 high-power fields (400x) and the number of vessels was evaluated in relation to the extension of the inflammatory infiltrate (0-3), to the bacillary index (0-6) and to the clinical forms. Angiogenesis, as marked by CD31 and CD105, was observed across the leprosy spectrum, compared with the controls. Additionally, there was a positive correlation between these markers with extension of the infiltrate (p <0.0001). For D2/40, lymphangiogenesis was observed in the tuberculoid form (p <0.0001). There was no statistical significance for values of CD105 detected in plasma by ELISA.
Conclusions/significance: Angiogenesis is present across the spectrum of leprosy and in its reactional forms. The increase in the number of vessels, as detected by CD31 and CD105 staining, is related to the extension of the inflammatory infiltrate. Samples from reactional lesions have a higher number of CD31+ and CD105+ stained vessels, which indicates their involvement in the pathophysiological mechanisms of the reactional states. The regression of lesions is accompanied by the regression of neovascularization. Drugs inhibiting angiogenesis may be relevant in the treatment of leprosy, in addition to multidrugtherapy, and in the prevention of the development of reactions.
Conflict of interest statement
Figures
Similar articles
-
Prognostic significance of angiogenesis evaluated by CD105 expression compared to CD31 in 905 breast carcinomas: correlation with long-term patient outcome.Int J Oncol. 2004 May;24(5):1197-204. Int J Oncol. 2004. PMID: 15067342
-
Endoglin is a better marker than CD31 in evaluation of angiogenesis in glioblastoma.Croat Med J. 2005 Jun;46(3):417-22. Croat Med J. 2005. PMID: 15861521
-
Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas.Acta Neuropathol. 2007 Aug;114(2):147-56. doi: 10.1007/s00401-007-0251-4. Epub 2007 Jun 27. Acta Neuropathol. 2007. PMID: 17594108
-
[Endoglin (CD105)--a target for visualization and anti-angiogenic therapy for malignant tumors].Vopr Onkol. 2015;61(6):898-907. Vopr Onkol. 2015. PMID: 26995976 Review. Russian.
-
Endoglin (CD105): a review of its role in angiogenesis and tumor diagnosis, progression and therapy.Anticancer Res. 2011 Jun;31(6):2283-90. Anticancer Res. 2011. PMID: 21737653 Review.
Cited by
-
The involvement of endothelial mediators in leprosy.Mem Inst Oswaldo Cruz. 2016 Oct;111(10):635-641. doi: 10.1590/0074-02760160122. Epub 2016 Oct 3. Mem Inst Oswaldo Cruz. 2016. PMID: 27706378 Free PMC article.
-
Cell-type deconvolution with immune pathways identifies gene networks of host defense and immunopathology in leprosy.JCI Insight. 2016 Sep 22;1(15):e88843. doi: 10.1172/jci.insight.88843. JCI Insight. 2016. PMID: 27699251 Free PMC article.
-
Differential Expression of MicroRNAs in Leprosy Skin Lesions.Front Immunol. 2017 Aug 25;8:1035. doi: 10.3389/fimmu.2017.01035. eCollection 2017. Front Immunol. 2017. PMID: 28970833 Free PMC article.
References
-
- Scollard DM, Adams LB, Gillis TP, Krahenbuhl JL, Truman RW et al. (2006) The continuing challenges of leprosy. Clin Microbiol Rev 19: 338-381. doi:10.1128/CMR.19.2.338-381.2006. PubMed: 16614253. - DOI - PMC - PubMed
-
- Costa C, Incio J, Soares R (2007) Angiogenesis and chronic inflammation: cause or consequence? Angiogenesis 10: 149-166. doi:10.1007/s10456-007-9074-0. PubMed: 17457680. - DOI - PubMed
-
- Goel S, Duda DG, Xu L, Munn LL, Boucher Y et al. (2011) Normalization of the vasculature for treatment of cancer and other diseases. Physiol Rev 91: 1071-1121. doi:10.1152/physrev.00038.2010. PubMed: 21742796. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical